Study explores promise, limitations of 18F-FLT in cancer imaging

05/20/2013 | MolecularImaging.net

A review published in The Journal of Nuclear Medicine found that while 18F-FLT has been seen as a promising tracer for imaging cancer proliferation, its performance falls short of the standard FDG. In one study, 18F-FDG showed higher sensitivity in detecting pancreatic tumors. In another study, 18F-FLT was found to have lower uptake than FDG in head and neck cancers. "As F-18 FLT finds more applications in proliferation imaging, its benefits and limitations will be better known," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD